135 related articles for article (PubMed ID: 37272790)
1. Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement.
Gong XH; Feng MX; Zhuang ZG; Yan YQ; Wang L; Ren HN; Zhu Y; Song Y; Qian LJ; Xu JR; Zhou Y; Xia Q
J Magn Reson Imaging; 2024 Mar; 59(3):1034-1042. PubMed ID: 37272790
[TBL] [Abstract][Full Text] [Related]
2. Editorial for "Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement".
Arenos-Abril J; Greer MC
J Magn Reson Imaging; 2024 Mar; 59(3):1043-1044. PubMed ID: 37285117
[No Abstract] [Full Text] [Related]
3. An evaluation of the association between radiological parameters and survival outcomes in pediatric patients with hepatoblastoma.
Sirichamratsakul K; Kritsaneepaiboon S; Sripornsawan P; Kanjanapradit K; Laochareonsuk W; Sangkhathat S
Pediatr Surg Int; 2022 Nov; 38(11):1591-1600. PubMed ID: 36097077
[TBL] [Abstract][Full Text] [Related]
4. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
[TBL] [Abstract][Full Text] [Related]
5. Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver transplantation for hepatoblastoma with caval extension.
Hort A; Karpelowsky J; Shun A; Thomas G
Pediatr Transplant; 2019 Jun; 23(4):e13409. PubMed ID: 30946509
[TBL] [Abstract][Full Text] [Related]
6. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
7. Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.
Murphy AJ; Ayers GD; Hilmes MA; Mukherjee K; Wilson KJ; Allen WM; Fernandez-Pineda I; Shinall MC; Zhao Z; Furman WL; McCarville MB; Davidoff AM; Lovvorn HN
J Pediatr Surg; 2013 Jun; 48(6):1239-48. PubMed ID: 23845613
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum uric acid is associated with the risk of advanced staging and vascular involvement in patients with hepatoblastoma: a 14-year retrospective study.
Zhou Y; Li J; Ma Y; Tang M; Yuan X; Shen L
Front Oncol; 2023; 13():1144349. PubMed ID: 37124543
[TBL] [Abstract][Full Text] [Related]
10. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
11. POST-TEXT III and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases.
Fuchs J; Cavdar S; Blumenstock G; Ebinger M; Schäfer JF; Sipos B; Warmann SW
Ann Surg; 2017 Aug; 266(2):318-323. PubMed ID: 27501172
[TBL] [Abstract][Full Text] [Related]
12. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
13. Surgical strategies for unresectable hepatoblastomas.
Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
[TBL] [Abstract][Full Text] [Related]
14. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review.
Ikeda H; Hachitanda Y; Tanimura M; Maruyama K; Koizumi T; Tsuchida Y
Cancer; 1998 May; 82(9):1789-96. PubMed ID: 9576303
[TBL] [Abstract][Full Text] [Related]
15. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Zheng C; Ye S; Liu W; Diao M; Li L
Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
[TBL] [Abstract][Full Text] [Related]
17. Strategy for hepatoblastoma with major vascular involvement: A guide for surgical decision-making.
Uchida H; Sakamoto S; Komine R; Kodama T; Nakao T; Okada N; Yanagi Y; Shimizu S; Fukuda A; Shioda Y; Kiyotani C; Matsumoto K; Yoneda A; Haga C; Yoshioka T; Miyazaki O; Nosaka S; Kasahara M
Surgery; 2023 Feb; 173(2):457-463. PubMed ID: 36473744
[TBL] [Abstract][Full Text] [Related]
18. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Ayllon Teran D; Gómez Beltran O; Ciria Bru R; Mateos González E; Peña Rosa MJ; Luque Molina A; López Cillero P; Briceño Delgado J
World J Gastroenterol; 2014 Aug; 20(29):10137-43. PubMed ID: 25110441
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
